Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005;50:103–22.
Muqit MM, Foot B, Walters SJ, Mudhar H, Roberts F, Rennie IG. Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma. Br J Ophthalmol. 2013;97:47–51.
Owen JL, et al. Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA et al. Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol. 2019;20:e699–e714.
Takahashi Y, Takahashi E, Nakakura S, Kitaguchi Y, Mupas-Uy J, Kakizaki H. Risk Factors for Local Recurrence or Metastasis of Eyelid Sebaceous Gland Carcinoma After Wide Excision With Paraffin Section Control. Am J Ophthalmol. 2016;171:67–74.
Zhou C, Wu F, Chai P, Shi Y, Ye J, Shi X, et al. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients. J Am Acad Dermatol. 2019;80:1608–17.
While B, Salvi S, Currie Z, Mudhar HS, Tan JH. Excision and delayed reconstruction with paraffin section histopathological analysis for periocular sebaceous carcinoma. Ophthalmic Plast Reconstr Surg. 2014;30:105–9.
Kibbi N, Worley B, Owen JL, Kelm RC, Bichakjian CK, Chandra S, et al. Sebaceous carcinoma: controversies and their evidence for clinical practice. Arch Dermatol Res. 2020;312:25–23.
Article CAS PubMed Google Scholar
Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M, Sagiv O, et al. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients. Br J Ophthalmol. 2019;103:980–4.
Cho KJ, Khang KS, Koh JS, Chung JH, Lee SS. Sebaceous carcinoma of the eyelids: frequent expression of c‑erbB‑2 oncoprotein. J Korean Med Sci. 2000;15:545–50.
Article CAS PubMed PubMed Central Google Scholar
Na HY, Choe JY, Shin SA, Choung HK, Oh S, Chung JH, et al. Proposal of a Provisional Classification of Sebaceous Carcinoma Based on Hormone Receptor Expression and HER2 Status. Am J Surg Pathol. 2016;40:1622–30.
留言 (0)